Vascular endothelial microparticles-incorporated microRNAs are altered in patients with diabetes mellitus

Table 3 Association of miR-126 levels with baseline characteristics

	Exp(B) (95 % CI)	p value
Age	0.981(0.937–1.026)	0.402
Male sex	1.480 (0.534–4.101)	0.451
Body mass index	1.031 (0.963–1.102)	0.381
Coronary artery disease	2.444 (1.086–5.051)	0.031
Arterial hypertension	0.410 (0.133–1.266)	0.121
Hyperlipoproteinemia	0.831 (0.354–1.953)	0.671
Smoking	1.227 (0.411–3.667)	0.714
Chronic kidney disease	1.393 (0.106–18.389)	0.801
Angiotensin converting enzyme inhibitors (ACEI)	0.803 (0.241–2.682)	0.722
Angiotensin receptor blockers (ARB)	0.634 (0.166–2.423)	0.505
Calcium channel blockers (CCB)	1.237 (0.462–3.310)	0.673
Diuretics	0.501 (0.227–1.103)	0.086
Statins	0.158 (0.040–0.632)	0.009
Nitrates	3.256 (0.263–40.306)	0.358
Aspirin	2.075 (0.550–7.825)	0.281
Clopidogrel	0.681 (0.295–1.573)	0.368

The coefficient of the continuous variables was relative to 1-U differences. Binary logistic regression according to the median of miR-126 level
Exp(B) exponentiation of the B coefficient, miR microRNA
Italic values indicate significance of p value (p < 0.05)

ISSN: 1475-2840